Invention Grant
- Patent Title: CTLA4-Ig immunoadhesins
-
Application No.: US17231848Application Date: 2021-04-15
-
Publication No.: US11254727B2Publication Date: 2022-02-22
- Inventor: Gregory A. Lazar , Matthew J. Bernett
- Applicant: Xencor, Inc.
- Applicant Address: US CA Monrovia
- Assignee: Xencor, Inc.
- Current Assignee: Xencor, Inc.
- Current Assignee Address: US CA Monrovia
- Agency: Proskauer Rose LLP
- Agent Fangli Chen
- Main IPC: C07K14/705
- IPC: C07K14/705 ; C07K16/46 ; A61K38/00 ; C07K19/00
Abstract:
The present application relates to CTLA4-Ig immunoadhesins that target CD80 and CD86, and their use, particularly for therapeutic purposes.
Public/Granted literature
- US20210230250A1 NOVEL CTLA4-IG IMMUNOADHESINS Public/Granted day:2021-07-29
Information query
